Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma.

Croci DO, Salatino M, Rubinstein N, Cerliani JP, Cavallin LE, Leung HJ, Ouyang J, Ilarregui JM, Toscano MA, Domaica CI, Croci MC, Shipp MA, Mesri EA, Albini A, Rabinovich GA.

J Exp Med. 2012 Oct 22;209(11):1985-2000. doi: 10.1084/jem.20111665. Epub 2012 Oct 1.

2.

KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.

Ma T, Patel H, Babapoor-Farrokhran S, Franklin R, Semenza GL, Sodhi A, Montaner S.

Angiogenesis. 2015 Oct;18(4):477-88. doi: 10.1007/s10456-015-9475-4. Epub 2015 Jun 20.

3.

Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma.

Jham BC, Ma T, Hu J, Chaisuparat R, Friedman ER, Pandolfi PP, Schneider A, Sodhi A, Montaner S.

PLoS One. 2011 Apr 29;6(4):e19103. doi: 10.1371/journal.pone.0019103.

4.

Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway.

Zhu X, Guo Y, Yao S, Yan Q, Xue M, Hao T, Zhou F, Zhu J, Qin D, Lu C.

Oncogene. 2014 Apr 10;33(15):1986-96. doi: 10.1038/onc.2013.136. Epub 2013 Apr 22.

PMID:
23604117
5.

Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma.

Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, Hale LP, Dong C, Cesarman E, Mesri EA, Goldschmidt-Clermont PJ.

Proc Natl Acad Sci U S A. 2009 May 26;106(21):8683-8. doi: 10.1073/pnas.0812688106. Epub 2009 May 8.

6.

A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.

Ma Q, Cavallin LE, Leung HJ, Chiozzini C, Goldschmidt-Clermont PJ, Mesri EA.

Antioxid Redox Signal. 2013 Jan 1;18(1):80-90. doi: 10.1089/ars.2012.4584. Epub 2012 Aug 20.

7.

Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.

Carroll PA, Kenerson HL, Yeung RS, Lagunoff M.

J Virol. 2006 Nov;80(21):10802-12. Epub 2006 Sep 6.

9.

NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.

Kim TH, Hur EG, Kang SJ, Kim JA, Thapa D, Lee YM, Ku SK, Jung Y, Kwak MK.

Cancer Res. 2011 Mar 15;71(6):2260-75. doi: 10.1158/0008-5472.CAN-10-3007. Epub 2011 Jan 28.

10.

Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma.

Masood R, Cai J, Tulpule A, Zheng T, Hamilton A, Sharma S, Espina BM, Smith DL, Gill PS.

Clin Cancer Res. 2001 Sep;7(9):2693-702.

11.

A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis.

Nam SY, Ko YS, Jung J, Yoon J, Kim YH, Choi YJ, Park JW, Chang MS, Kim WH, Lee BL.

Br J Cancer. 2011 Jan 4;104(1):166-74. doi: 10.1038/sj.bjc.6606020. Epub 2010 Nov 30.

12.

Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors.

Veeranna RP, Haque M, Davis DA, Yang M, Yarchoan R.

J Virol. 2012 Jan;86(2):1097-108. doi: 10.1128/JVI.05167-11. Epub 2011 Nov 16.

13.

Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I.

Catrina SB, Botusan IR, Rantanen A, Catrina AI, Pyakurel P, Savu O, Axelson M, Biberfeld P, Poellinger L, Brismar K.

Clin Cancer Res. 2006 Aug 1;12(15):4506-14.

14.

Latent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypes.

DiMaio TA, Gutierrez KD, Lagunoff M.

PLoS Pathog. 2011 Dec;7(12):e1002424. doi: 10.1371/journal.ppat.1002424. Epub 2011 Dec 8.

15.

An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia.

Martin D, Galisteo R, Ji Y, Montaner S, Gutkind JS.

Oncogene. 2008 Mar 20;27(13):1844-52. Epub 2007 Oct 15.

PMID:
17934524
16.

Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions.

Taraboletti G, Benelli R, Borsotti P, Rusnati M, Presta M, Giavazzi R, Ruco L, Albini A.

J Pathol. 1999 May;188(1):76-81.

PMID:
10398144
17.

Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation.

Ojala PM, Schulz TF.

Semin Cancer Biol. 2014 Jun;26:69-77. doi: 10.1016/j.semcancer.2014.01.008. Epub 2014 Jan 28. Review.

PMID:
24486643
18.

Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma.

Liu R, Gong M, Li X, Zhou Y, Gao W, Tulpule A, Chaudhary PM, Jung J, Gill PS.

Blood. 2010 Jul 15;116(2):297-305. doi: 10.1182/blood-2009-12-257154. Epub 2010 May 4.

19.

Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma.

Ma T, Jham BC, Hu J, Friedman ER, Basile JR, Molinolo A, Sodhi A, Montaner S.

Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14363-8. doi: 10.1073/pnas.1001065107. Epub 2010 Jul 26.

20.

Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1.

Ye FC, Blackbourn DJ, Mengel M, Xie JP, Qian LW, Greene W, Yeh IT, Graham D, Gao SJ.

J Virol. 2007 Apr;81(8):3980-91. Epub 2007 Feb 7.

Items per page

Supplemental Content

Write to the Help Desk